Terms: = Liver cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF
236 results:
1. Compressed sensing with deep learning reconstruction: Improving capability of gadolinium-EOB-enhanced 3D T1WI.
Nagata H; Ohno Y; Yoshikawa T; Yamamoto K; Shinohara M; Ikedo M; Yui M; Matsuyama T; Takahashi T; Bando S; Furuta M; Ueda T; Ozawa Y; Toyama H
Magn Reson Imaging; 2024 May; 108():67-76. PubMed ID: 38309378
[TBL] [Abstract] [Full Text] [Related]
2. [Minimally Invasive Conversion Hepatectomy for Advanced Hepatocellular Carcinoma].
Sakai H; Goto Y; Shimose S; Niizeki T; Kawaguchi T; Akiba J; Yano H; Akagi Y; Fujita F; Hisaka T
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1572-1574. PubMed ID: 38303345
[TBL] [Abstract] [Full Text] [Related]
3. Measurement of Trogocytosis: Quantitative Analyses Validated with Rigorous Controls.
Taylor RP; Lindorfer MA
Curr Protoc; 2023 Oct; 3(10):e897. PubMed ID: 37830752
[TBL] [Abstract] [Full Text] [Related]
4. Exploration of a screening model for intrahepatic cholangiocarcinoma patients prone to cuproptosis and mechanisms of the susceptibility of CD274-knockdown intrahepatic cholangiocarcinoma cells to cuproptosis.
Shen Z; Cai J; Tao L; Zheng J; Ye Z; Liu Y; Pan H; Wang Y; Xu J; Liang X
Cancer Gene Ther; 2023 Dec; 30(12):1663-1678. PubMed ID: 37828105
[TBL] [Abstract] [Full Text] [Related]
5. Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis.
Jiang Z; Wu F; Laise P; Takayuki T; Na F; Kim W; Kobayashi H; Chang W; Takahashi R; Valenti G; Sunagawa M; White RA; Macchini M; Renz BW; Middelhoff M; Hayakawa Y; Dubeykovskaya ZA; Tan X; Chu TH; Nagar K; Tailor Y; Belin BR; Anand A; Asfaha S; Finlayson MO; Iuga AC; Califano A; Wang TC
Cell Stem Cell; 2023 Aug; 30(8):1091-1109.e7. PubMed ID: 37541213
[TBL] [Abstract] [Full Text] [Related]
6. Preoperative Chemotherapy Followed by Hepatectomy for Potentially Resectable UICC7 Stage IIIA, IIIB Hepatocellular Carcinoma; A Phase II Clinical Trial.
Goto Y; Niizeki T; Fukutomi S; Shirono T; Shimose S; Iwamoto H; Kojima S; Kanno H; Uchino Y; Sasaki S; Shirahama N; Muroya D; Nomura Y; Akashi M; Nakayama G; Hirakawa Y; Sato T; Yoshitomi M; Sakai H; Hisaka T; Kakuma T; Koga H; Torimura T; Akagi Y; Okuda K
Kurume Med J; 2023 Sep; 68(3.4):239-245. PubMed ID: 37518005
[TBL] [Abstract] [Full Text] [Related]
7. Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis.
Narasimman M; Hernaez R; Cerda V; Lee M; Sood A; Yekkaluri S; Khan A; Quirk L; Liu Y; Kramer JR; Craddock Lee S; Murphy CC; Tiro JA; Singal AG
Hepatology; 2024 Jan; 79(1):107-117. PubMed ID: 37401857
[TBL] [Abstract] [Full Text] [Related]
8. Identification of Atezolizumab Plus Bevacizumab Prognostic Index
Persano M; Rimini M; Tada T; Suda G; Shimose S; Kudo M; Cheon J; Finkelmeier F; Lim HY; Presa J; Masi G; Yoo C; Lonardi S; Pressiani T; Piscaglia F; Kumada T; Rimassa L; Scartozzi M; Cascinu S; Casadei-Gardini A;
Anticancer Res; 2023 Apr; 43(4):1599-1610. PubMed ID: 36974779
[TBL] [Abstract] [Full Text] [Related]
9. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.
Shahini E; Pasculli G; Solimando AG; Tiribelli C; Cozzolongo R; Giannelli G
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901717
[TBL] [Abstract] [Full Text] [Related]
10. Telephone follow-up contributes to improving adherence and treatment duration in patients with hepatocellular carcinoma treated with lenvatinib.
Tsumura S; Shimose S; Niizeki T; Kuboyama E; Iwamoto H; Tanaka M; Moriyama E; Shirono T; Takaki K; Noda Y; Nakano M; Inoue M; Tsustumi K; Kuromatsu R; Koga H; Higuchi K; Kawaguchi T
J Gastroenterol Hepatol; 2023 Jul; 38(7):1140-1147. PubMed ID: 36880677
[TBL] [Abstract] [Full Text] [Related]
11. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity.
Iwamoto H; Shimose S; Shirono T; Niizeki T; Kawaguchi T
Clin Mol Hepatol; 2023 Jul; 29(3):593-604. PubMed ID: 36775834
[TBL] [Abstract] [Full Text] [Related]
12. [A Case of Advanced Esophageal cancer with Single liver Metastasis Who Underwent Surgery after Induction Chemoradiotherapy].
Fujiwara Y; Kawada H; Hanabata Y
Gan To Kagaku Ryoho; 2022 Dec; 49(13):2001-2003. PubMed ID: 36733071
[TBL] [Abstract] [Full Text] [Related]
13. Photoacoustic/fluorescence dual-modality cyanine-based probe for real-time imaging of endogenous cysteine and in situ diagnosis of cervical cancer in vivo.
Zou X; Zhao Y; Lin W
Anal Chim Acta; 2023 Jan; 1239():340713. PubMed ID: 36628718
[TBL] [Abstract] [Full Text] [Related]
14. Synthetic-to-real domain adaptation with deep learning for fitting the intravoxel incoherent motion model of diffusion-weighted imaging.
Huang H; Liu B; Xu Y; Zhou W
Med Phys; 2023 Mar; 50(3):1614-1622. PubMed ID: 36308503
[TBL] [Abstract] [Full Text] [Related]
15. Protein succinylation associated with the progress of hepatocellular carcinoma.
Bai W; Cheng L; Xiong L; Wang M; Liu H; Yu K; Wang W
J Cell Mol Med; 2022 Nov; 26(22):5702-5712. PubMed ID: 36308411
[TBL] [Abstract] [Full Text] [Related]
16. High frame-rate contrast enhanced ultrasound (HIFR-CEUS) in the characterization of small hepatic lesions in cirrhotic patients.
Giangregorio F; Garolfi M; Mosconi E; Ricevuti L; Debellis MG; Mendozza M; Esposito C; Vigotti E; Cadei D; Abruzzese D
J Ultrasound; 2023 Mar; 26(1):71-79. PubMed ID: 36227456
[TBL] [Abstract] [Full Text] [Related]
17. DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC.
Kondo Y; Morosawa T; Minami S; Tanaka Y
Sci Rep; 2022 Oct; 12(1):16868. PubMed ID: 36207618
[TBL] [Abstract] [Full Text] [Related]
18. sdha/B reduction promotes hepatocellular carcinoma by facilitating the deNEDDylation of cullin1 and stabilizing YAP/TAZ.
Yuan T; Zhou T; Qian M; Du J; Liu Y; Wang J; Li Y; Fan G; Yan F; Dai X; Li X; Wu Y; Dong X; He Q; Zhu H; Yang B
Hepatology; 2023 Jul; 78(1):103-119. PubMed ID: 35713976
[TBL] [Abstract] [Full Text] [Related]
19. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N
Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452
[TBL] [Abstract] [Full Text] [Related]
20. Chondroitin sulfate deposited on foxtail millet prolamin/caseinate nanoparticles to improve physicochemical properties and enhance cancer therapeutic effects.
Chen X; Wu YC; Gong PX; Zhang YH; Li HJ
Food Funct; 2022 May; 13(9):5343-5352. PubMed ID: 35466985
[TBL] [Abstract] [Full Text] [Related]
[Next]
